Dopamine D1-histamine H3 Receptor Heteromers Provide a Selective Link to MAPK Signaling in GABAergic Neurons of the Direct Striatal Pathway
Open Access
- 1 February 2011
- journal article
- Published by Elsevier BV
- Vol. 286 (7), 5846-5854
- https://doi.org/10.1074/jbc.m110.161489
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanismsCurrent Opinion in Pharmacology, 2010
- Calcium signaling cascade links dopamine D1–D2 receptor heteromer to striatal BDNF production and neuronal growthProceedings of the National Academy of Sciences of the United States of America, 2009
- G‐protein‐coupled receptor heteromers or how neurons can display differently flavoured patterns in response to the same neurotransmitterBritish Journal of Pharmacology, 2009
- Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptorsBritish Journal of Pharmacology, 2009
- Building a new conceptual framework for receptor heteromersNature Chemical Biology, 2009
- Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal functionNeuropharmacology, 2008
- G‐protein‐coupled receptor heteromers: function and ligand pharmacologyBritish Journal of Pharmacology, 2008
- D1–D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of G q /11 in the striatumProceedings of the National Academy of Sciences of the United States of America, 2007
- Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and FunctionPublished by Elsevier BV ,2006
- Depolarization‐induced suppression of inhibition mediated by endocannabinoids at synapses from fast‐spiking interneurons to medium spiny neurons in the striatumEuropean Journal of Neuroscience, 2006